Cancer Research UK logo.
SearchDonate
  • Search

A trial of radioembolisation with TheraSphere before sorafenib for liver cancer (STOP-HCC)

Overview

Cancer types:

Liver cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at a treatment called radioembolisation before starting a drug called sorafenib for liver cancer. It is for people who have a type of liver cancer called hepatocellular carcinoma that can’t be removed with surgery.

Recruitment start: 20 April 2015

Recruitment end: 5 September 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Meyer

Supported by

Biocompatibles UK Limited

BTG International Ltd

Last reviewed: 08 Jan 2018

CRUK internal database number: 12841

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.